Endo USA Inc., a Keenova Therapeutics Company
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Endo USA Inc., a Keenova Therapeutics Company sits in the top decile of US sponsors by registered trial count (#334 of 15,742 sponsors by registered trial count).
Endo USA Inc., a Keenova Therapeutics Company: 61 sponsored US clinical trials, none currently recruiting.
Endo USA Inc., a Keenova Therapeutics Company sponsors 61 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 46 completed. 29 of these trials are in Phase 3-4 (later-stage) and 23 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
Endo USA Inc., a Keenova Therapeutics Company ranks in the top decile of sponsors by registered trial count (#334 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
46 of 61 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
61 total, page 2 of 2
Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
NCT00904098
EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study
NCT00216255
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
NCT00637572
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797
Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee
NCT00904462
A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain
NCT00904111
Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain
NCT00904397
Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee
NCT00904605
A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain
NCT00904020
A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine
NCT00644033
Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy
NCT00904280
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 19 |
| Phase 3 | 22 |
| Phase 4 | 7 |
How the Endo USA Inc., a Keenova Therapeutics Company archive is shaped
61 indexed studies, none listed as recruiting (0% open); 46 completed (75%).
Phase mix: 29 late (III/IV) vs 23 early (I/II) (balanced across stages).
Therapeutic area indexing for this sponsor is limited in the public registry.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Endo USA Inc., a Keenova Therapeutics Company: archived-pipeline peers nationwide
Peers matched on 61 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Endo USA Inc., a Keenova Therapeutics Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 61 archived trials
- NICHD Neonatal Research Network · 61 trials · 7% recruiting
- Oregon Research Institute · 62 trials · 8% recruiting
- Power Life Sciences · 62 trials · 2% recruiting
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 60 trials · 22% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Endo USA Inc., a Keenova Therapeutics Company page
61 registered trials is a research-attention snapshot, not an endorsement of Endo USA Inc., a Keenova Therapeutics Company or any single study.
- None of Endo USA Inc., a Keenova Therapeutics Company's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Endo USA Inc., a Keenova Therapeutics Company pipeline card: 61 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.